That’s a tough endpoint 43% even with early covi
Post# of 148278
(Total Views: 622)
Posted On: 12/17/2020 7:53:49 PM
That’s a tough endpoint 43% even with early covid . Thoughts?
The trial was powered to achieve a
primary endpoint of 43% reduction in mortality at 30 days for treatment with remestemcel-L on top of
maximal care in a trial of 300 patients. This projected mortality reduction was based on pilot data
The trial was powered to achieve a
primary endpoint of 43% reduction in mortality at 30 days for treatment with remestemcel-L on top of
maximal care in a trial of 300 patients. This projected mortality reduction was based on pilot data
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼